All articles tagged: Malignant neoplasm of colon (C18)


Evalytics 01 April at 06.10 PM A new type of bacteria was found in 50% of colon cancers. Many were aggressive cases. A newly identified bacteria found in half of colon tumors may be linked to aggressive colon cancer, according to a study. Researchers discovered Fusobacterium nucleatum bacteria in 52% of the tumors studied. This finding suggests a potential role of gut bacteria in the development or progression of colon cancer. 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Evalytics 19 March at 06.39 AM A new way to screen for colon cancer may be on the horizon, study suggests The potential approval of the first blood test for colorectal cancer this year could mark a significant breakthrough in cancer detection, potentially increasing the number of diagnoses for the second-highest cause of cancer death in the United States. While experts emphasize that the test would not replace colonoscopies, it could offer a less invasive alternative and encourage more people to under 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Evalytics 29 January at 05.53 PM 'Cancer-cooling' protein puts bowel cancer on ice ANU researchers discovered that Ku70, an immune protein, can be activated to inhibit bowel cancer by detecting damaged DNA in cells, potentially improving screening and treatment. 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Evalytics 22 January at 02.24 PM Colon cancer is killing more younger men and women than ever, new report finds A report from NBC News highlights a concerning trend of increasing colon cancer deaths among younger men and women. The article discusses the rise in cases and emphasizes the importance of early screening and awareness. 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 28 November at 05.03 PM Recent Decline in Risk for CRC Recurrence Seen in Stage I to III Disease From 2004 to 2019, the risk for recurrence of colorectal cancer (CRC) decreased in patients with stages I to III disease, according to a study published online Nov. 16 in JAMA Oncology to coincide with the annual meeting of the Danish Surgical Society, held from Nov. 16 to 17 in Copenhagen.Jesper Nors, M.D., from Aarhus University Hosp # Surgery # Gastroenterology # Hematology & Oncology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 15 November at 11.13 PM Type 2 Diabetes Linked to Increased Risk for Colorectal Cancer Type 2 diabetes is associated with an increased risk for colorectal cancer (CRC), with increased associations for those without colonoscopy screening and with smoking history, according to a study published online Nov. 14 in JAMA Network Open.Thomas Lawler, Ph.D., from the University of Wisconsin Carbone Cancer Center in Madison, and # Diabetes & Endocrinology # Gastroenterology # Internal Medicine # Family Practice 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

HealthDay 07 November at 04.44 PM Advanced Neoplasia Risk Increased at Upper Range of Negative FIT Values Individuals in the upper range of fecal immunochemical test (FIT)-negative screening have an increased risk for advanced neoplasia (AN), according to a research letter published online Nov. 7 in the Annals of Internal Medicine.Tobias Niedermaier, Ph.D., from the German Cancer Research Center in Heidelberg, and colleagues provided a dose # Gastroenterology # Internal Medicine # Pathology # Hematology & Oncology 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn


Medical xPress 30 June at 07.40 AM Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts say Intrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 27 June at 03.19 PM Immunoglobulin Replacement Therapy Beneficial for Blood Cancers Immunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 26 June at 04.59 PM When Was the Last Time You Really Talked With Your Patient? My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 23 June at 09.21 PM Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2D ORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 22 June at 06.00 PM Fenofibrate Slows Diabetic Retinopathy Progression ORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 22 June at 06.00 PM Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic Stroke TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

Medical xPress 22 June at 05.20 PM Lawsuit could challenge trust in Ozempic and other popular weight loss drugs The manufacturers of the most popular weight loss drugs are being challenged in court. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 21 June at 03.38 PM Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is Low The overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 13 June at 06.56 PM Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break? Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 08 June at 04.00 PM Here Are the Top Supreme Court Health Cases to Watch By early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn